Learning how to reconstitute peptides correctly is the single most important bench skill in a peptide laboratory: a lyophilised vial is a dry, stable powder, and the moment diluent enters it the clock starts on chemical stability, sterility and concentration accuracy. This guide covers vial anatomy, diluent selection, the concentration arithmetic, a validated step-by-step protocol and a full reference grid — written for qualified researchers handling research-use-only material.
Key takeaways
- Reconstitution is simply dissolving a lyophilised (freeze-dried) peptide cake in a known volume of diluent to produce a solution of known concentration in mg/mL.
- The core arithmetic never changes: mass in the vial (mg) ÷ diluent volume (mL) = concentration (mg/mL). Multiply mg/mL by 100 to get micrograms per 0.1 mL.
- Bacteriostatic water (water containing 0.9% benzyl alcohol) is the usual diluent when a solution will be drawn from repeatedly; sterile water and 0.9% sodium chloride are single-use options.
- Never inject diluent directly onto the cake under pressure — run it down the inside glass wall and let the cake dissolve without shaking.
- Peptides adsorb to glass and plastic; at low concentrations a large fraction of peptide can be lost to container walls, so very dilute working stocks are avoided where possible.
- Once in solution, refrigerate at 2–8 °C, protect from light, label with peptide, batch, concentration and date, and minimise repeated freezing and thawing.
- All material described here is supplied strictly for in-vitro laboratory research; nothing on this page is a dosing instruction for a person or animal.
What does reconstituting a research peptide mean?
Reconstitution is the process of dissolving a freeze-dried peptide back into a liquid of known volume, so that a solid of known mass becomes a solution of known concentration. Nothing is created or destroyed — you are converting “5 mg of powder in a vial” into “2 mL of a 2.5 mg/mL solution”.
Research peptides are supplied lyophilised because water is the enemy of peptide shelf life. Freeze-drying removes solvent under vacuum from the frozen state, leaving an amorphous cake in which hydrolysis, deamidation and oxidation proceed orders of magnitude more slowly than in solution. Wang’s foundational review of solid protein pharmaceuticals sets out why residual moisture, glass-transition temperature and excipient choice dominate long-term solid-state stability.1
The consequence for the bench is straightforward: the dry vial is the stable form, and reconstitution is the point at which the material becomes perishable. Everything in this guide is designed around that fact — accuracy first, then minimising the time and stress the peptide spends in solution.
This guide is written for laboratory personnel preparing in-vitro stock solutions. It is not a set of instructions for administering anything to a person or an animal, and no quantity below should be read as such. Quantities are expressed only as solution concentrations for assay preparation.
Anatomy of a lyophilised peptide vial
A research peptide vial has four functional parts: a coloured flip-off cap, an aluminium crimp seal, a butyl or bromobutyl rubber stopper, and a borosilicate glass body containing the lyophilised cake. Understanding each part prevents the two most common handling errors — puncturing the wrong surface and losing vacuum before the diluent is ready.
The flip cap is a dust cover only. Removing it exposes the central circle of the rubber stopper, which is the only surface that should ever be punctured. The surrounding aluminium ring stays in place and holds the stopper against the glass; prising it off destroys the seal and the vial’s integrity.
Most correctly lyophilised vials are sealed under partial vacuum or an inert headspace. That vacuum is useful: when the needle enters, the vial will actively draw diluent in, and the plunger may move on its own. Let it. Fighting the vacuum by forcing the plunger creates a high-velocity jet that shears the cake and foams the solution.
The cake itself tells you something before you add anything. A well-made cake is a compact white or off-white disc or a thin dispersed film that matches the labelled mass. A cake that has collapsed into a sticky glassy residue, or that rattles as loose crystalline powder when the labelled product should be amorphous, is worth photographing and querying against the batch certificate of analysis before use.
Choosing a diluent: bacteriostatic water, sterile water, saline or acid
The right diluent depends on how many times the solution will be entered and how soluble the peptide is. Bacteriostatic water — water for injection containing 0.9% (9 mg/mL) benzyl alcohol as an antimicrobial preservative — is the default for stock solutions that will be sampled repeatedly, because the preservative suppresses microbial growth introduced at each puncture.
Sterile water and 0.9% sodium chloride contain no preservative and are appropriate for solutions consumed in a single session. Where a peptide is poorly soluble in neutral water, established peptide chemistry protocols recommend selecting the solvent from the peptide’s net charge: dilute acetic acid for basic peptides, dilute ammonium bicarbonate for acidic peptides, and small volumes of an organic co-solvent such as DMSO or acetonitrile for strongly hydrophobic sequences, followed by dropwise dilution into the aqueous buffer with constant gentle agitation.2
Benzyl alcohol is not chemically inert towards every peptide or protein. Studies on recombinant proteins in reconstituted lyophilised formulations have shown that benzyl alcohol can promote partial unfolding and accelerate aggregation in susceptible molecules, an effect that scales with preservative concentration and time in solution.3,4 For short synthetic peptides this is rarely limiting, but it is a real reason to prefer preservative-free diluent for structurally complex or aggregation-prone material intended for immediate single-session use.
A preserved multi-draw container also has a finite in-use window. USP General Chapter <797> caps the in-use period for a preserved multiple-dose container at the assigned beyond-use date or 28 days, whichever is shorter, and only where antimicrobial effectiveness has been demonstrated under USP <51>.5 Twenty-eight days is a ceiling, not an entitlement.
| Diluent | Composition | Preserved? | Typical research use | Main limitation |
|---|---|---|---|---|
| Bacteriostatic water | Water for injection + 0.9% benzyl alcohol | Yes | Stock solutions entered on multiple occasions over days to weeks | Benzyl alcohol can promote unfolding/aggregation in susceptible molecules |
| Sterile water for injection | Water for injection only | No | Single-session preparations; assays sensitive to organic preservatives | No microbial suppression after first entry |
| 0.9% sodium chloride | Isotonic saline | No | Where ionic strength matters to the assay; some solubility improvement | Adds Na⁺/Cl⁻ that may interfere with downstream analysis |
| 0.1–1% acetic acid | Dilute aqueous acid | No | Basic (net positive) peptides with poor neutral-water solubility | Low pH; must be compatible with the assay buffer |
| 0.1 M ammonium bicarbonate | Volatile buffer, ~pH 8 | No | Acidic (net negative) peptides | Volatile; not suitable for long storage |
| DMSO or acetonitrile (co-solvent) | Organic, used at low final percentage | No | Strongly hydrophobic sequences that will not wet in water | Solvent effects on cells and on chromatography; dilute dropwise |
The concentration maths, explained once
Peptide reconstitution arithmetic reduces to one division and one multiplication. Concentration (mg/mL) = peptide mass in the vial (mg) ÷ volume of diluent added (mL). To express the same solution as micrograms per 0.1 mL, multiply the mg/mL figure by 100.
Worked example: a 10 mg vial reconstituted with 2 mL of bacteriostatic water gives 10 ÷ 2 = 5 mg/mL. Each 0.1 mL of that solution therefore contains 0.5 mg, which is 500 micrograms. Each 0.01 mL contains 50 micrograms. Nothing else is needed — no molecular weight, no conversion factor.
Two points routinely trip people up. First, adding 2 mL of diluent to a vial does not produce exactly 2 mL of solution: the dissolved solid contributes a small volume of its own. For a few milligrams of peptide in millilitres of water the error is well under 1% and is normally ignored, but for concentrated stocks in the tens of mg/mL it is worth acknowledging in the record.
Second, the labelled mass is peptide as supplied, which for a salt-form peptide includes counter-ions and residual water. The net peptide content — the fraction of the weighed mass that is actual peptide backbone — can be materially lower than 100%, and where an experiment depends on molar accuracy the amino acid analysis figure on the certificate of analysis should be used rather than the nominal vial label.
Step-by-step peptide reconstitution protocol
The protocol below is the standard aseptic sequence for reconstituting a lyophilised research peptide into a stock solution of defined concentration. Work in a clean, draught-free area, ideally a laminar flow cabinet, with all consumables laid out before the first vial is opened.
- Calculate first, open second. Decide the target concentration and derive the diluent volume before touching a vial: volume (mL) = mass (mg) ÷ target concentration (mg/mL). Write it down.
- Equilibrate both vials. Allow the sealed peptide vial and the diluent to reach room temperature. Opening a cold vial draws moist air onto a cold cake, and condensation on a hygroscopic lyophilisate is the fastest way to degrade what is left in the vial.
- Remove flip caps and disinfect. Flip off the plastic caps from both the peptide vial and the diluent vial, swab each exposed rubber stopper with a 70% isopropanol wipe, and let both dry completely. Alcohol carried into the vial on a wet stopper enters your solution.
- Draw the diluent. Using a fresh sterile syringe and needle, withdraw exactly the calculated volume of diluent. Invert, tap out air bubbles, and expel to the exact graduation. Air in the barrel is the commonest source of volume error.
- Introduce the diluent down the wall. Insert the needle through the centre of the peptide vial’s stopper at a shallow angle so the tip touches the inner glass wall above the cake. Release the plunger slowly and let residual vacuum assist; the stream should trickle down the glass, never jet onto the cake.
- Withdraw and let it stand. Remove the needle, discard it into a sharps container, and leave the vial upright and undisturbed for two to five minutes. Most short peptides dissolve almost entirely during this rest period.
- Swirl, never shake. If solid remains, roll the vial gently between the palms or swirl it in a slow circle. Shaking or vortexing generates an air–liquid interface, and interfacial stress is a well-documented driver of protein and peptide aggregation and particle formation.6
- Inspect against light. Hold the vial against a dark background under good light. The finished solution should be clear and free of visible particles, fibres or haze. GHK-Cu solutions are an intended exception — the copper(II) complex gives a distinct blue solution.
- Label immediately. Peptide name, batch or lot number, concentration in mg/mL, diluent used, date and time of reconstitution, and the initials of the person who prepared it.
- Refrigerate and protect from light. Move the labelled vial to 2–8 °C. If any part of the stock will not be used within days, consider dividing it into single-use aliquots before the first freeze so that the whole stock is never thawed twice.
Reconstitution reference table (2, 5, 10 and 15 mg vials)
The grid below is a concentration reference for solution preparation. Find the labelled mass of your vial in the first column and the diluent volume you intend to add, and read off the resulting stock concentration and the amount contained in a 0.1 mL sample of that stock.
| Vial mass | Diluent added | Stock concentration | Per 0.1 mL | Per 0.01 mL | 0.1 mL samples per vial |
|---|---|---|---|---|---|
| 2 mg | 1 mL | 2.00 mg/mL | 200 mcg | 20 mcg | 10 |
| 2 mg | 2 mL | 1.00 mg/mL | 100 mcg | 10 mcg | 20 |
| 2 mg | 3 mL | 0.67 mg/mL | 66.7 mcg | 6.7 mcg | 30 |
| 5 mg | 1 mL | 5.00 mg/mL | 500 mcg | 50 mcg | 10 |
| 5 mg | 2 mL | 2.50 mg/mL | 250 mcg | 25 mcg | 20 |
| 5 mg | 3 mL | 1.67 mg/mL | 166.7 mcg | 16.7 mcg | 30 |
| 10 mg | 1 mL | 10.00 mg/mL | 1,000 mcg | 100 mcg | 10 |
| 10 mg | 2 mL | 5.00 mg/mL | 500 mcg | 50 mcg | 20 |
| 10 mg | 3 mL | 3.33 mg/mL | 333.3 mcg | 33.3 mcg | 30 |
| 15 mg | 1 mL | 15.00 mg/mL | 1,500 mcg | 150 mcg | 10 |
| 15 mg | 2 mL | 7.50 mg/mL | 750 mcg | 75 mcg | 20 |
| 15 mg | 3 mL | 5.00 mg/mL | 500 mcg | 50 mcg | 30 |
How to choose the diluent volume
Three practical constraints usually decide it. The first is measurement resolution: if the sampling device graduates in 0.01 mL, a stock so concentrated that a working sample is 0.005 mL cannot be measured reproducibly, so dilute further. The second is adsorption: very dilute peptide solutions lose a disproportionate fraction of their content to container walls, so avoid going more dilute than the assay requires.
The third is time in solution. A stock that will take three months to consume is a stock that spends three months degrading. Where a large vial will be used slowly, reconstituting into a modest volume and then aliquoting into single-use portions for frozen storage is generally preferable to keeping one large refrigerated stock.
Troubleshooting: cloudy, foaming or undissolved solutions
Most reconstitution problems have three causes: the peptide is genuinely insoluble in the chosen diluent, the solution has been mechanically stressed, or the material has already degraded. The table below separates them.
| Observation | Likely cause | Action |
|---|---|---|
| Cake will not wet; powder floats | Hydrophobic sequence; neutral water is the wrong solvent | Test a small portion in dilute acetic acid (basic peptides) or ammonium bicarbonate (acidic peptides) before committing the whole vial |
| Persistent fine haze after 10 minutes | Partial dissolution or early aggregation | Rest longer at room temperature with gentle swirling; do not shake. If haze persists, the material should not be used for quantitative work |
| Thick foam on the surface | Diluent jetted onto the cake, or the vial was shaken | Let the foam collapse before drawing; foam entrains air and biases volume measurement. Prevent by adding diluent down the wall |
| Visible fibres or specks | Particulate contamination from the stopper or environment | Discard. Coring of the stopper by a blunt or repeatedly reused needle is a common source |
| Blue solution | Expected for copper-complexed peptides such as GHK-Cu and AHK-Cu | Normal. The colour is the Cu(II) coordination complex, not contamination |
| Yellowing over time | Oxidative or Maillard-type chemistry during storage | Discontinue quantitative use; check storage temperature and light exposure against the batch record |
| Recovered concentration lower than expected | Adsorption to glass or plastic, especially in dilute solutions | Use low-binding tubes, keep the volume-to-surface-area ratio high, and avoid unnecessary intermediate dilutions7 |
Adsorptive loss deserves emphasis because it is invisible. In a controlled study of cationic peptides in borosilicate glass and polypropylene containers, only a small fraction of peptide remained in solution at low micromolar concentrations, with the majority lost to container walls within seconds of handling; low-binding tubes substantially reduced the effect.7 Any protocol that assumes nominal concentration equals delivered concentration at very low working concentrations is likely to be wrong.
Labelling, storage and records after reconstitution
Once a peptide is in solution its degradation pathways switch on. Manning and colleagues’ review of protein pharmaceutical stability catalogues the principal chemical routes — deamidation of asparagine and glutamine, oxidation of methionine, cysteine and tryptophan, hydrolysis at labile Asp-Pro bonds, and disulfide scrambling — alongside the physical routes of aggregation and surface adsorption.8 Every one of them runs faster in water, faster at higher temperature, and faster with more interfacial area.
The practical controls follow directly. Refrigerate at 2–8 °C for short-term working stocks. For longer holds, freeze at −20 °C or below, in single-use aliquots so that no portion is thawed more than once. Protect from light, particularly for peptides containing tryptophan or tyrosine. Keep the headspace small and avoid transferring between containers unnecessarily.
The label is part of the experiment. A stock labelled only “BPC-157” is unusable in a regulated or auditable setting; a stock labelled “BPC-157, batch 24071, 2.5 mg/mL in bacteriostatic water, prepared 10/09/2026, AJ” can be traced to a certificate of analysis and reproduced. Where a batch COA is available — GenoPept publishes per-batch HPLC and mass spectrometry reports at /coa-certificates/ — the batch number on the label is the link between the bench and the analytical record.
Finally, keep the arithmetic in the notebook, not just the result. Recording “10 mg vial + 2.0 mL bacteriostatic water = 5.0 mg/mL” makes an error recoverable months later; recording “5 mg/mL” alone does not.
Reconstitution supplies in the GenoPept store
Frequently asked questions
How much bacteriostatic water do I add to a 5 mg peptide vial?
There is no single correct volume — the volume you add sets the concentration. Adding 1 mL to a 5 mg vial gives a 5 mg/mL stock (500 mcg per 0.1 mL); 2 mL gives 2.5 mg/mL (250 mcg per 0.1 mL); 5 mL gives 1 mg/mL (100 mcg per 0.1 mL). Choose the volume that puts your intended sampling amount at a volume your measuring device can read accurately.
Can I use ordinary distilled water to reconstitute a research peptide?
No. Distilled or deionised water from a laboratory tap is not sterile and contains no antimicrobial preservative, so any solution made with it can support microbial growth and may carry endotoxin. Use sterile water for injection for single-session preparations, or bacteriostatic water where the stock will be entered more than once.
Why must the diluent run down the side of the vial?
A jet of liquid striking a lyophilised cake directly shears the solid, creates a large air–liquid interface and generates foam. Interfacial stress is a documented trigger for peptide and protein aggregation and particle formation. Directing the stream down the inner glass wall lets the cake hydrate gently from beneath, which usually dissolves it faster as well as more safely.
How long is a reconstituted peptide solution usable?
It depends on the peptide, the diluent and the storage temperature, and the batch data should govern it. As a general framework, preserved multi-draw solutions kept at 2–8 °C are typically worked with over a period of days to a few weeks, with USP General Chapter <797> capping the in-use period of a preserved multiple-dose container at 28 days or the assigned beyond-use date, whichever is shorter.
What does it mean if the solution is cloudy after reconstitution?
Cloudiness means undissolved or aggregated material. The usual causes are a peptide that is poorly soluble in neutral water, insufficient rest time, or mechanical stress from shaking. Allow more time at room temperature with gentle swirling. If haze persists, the solution should not be used for quantitative work, because the concentration in the liquid phase is no longer the nominal concentration.
Does reconstituted peptide need to be frozen?
Not for short-term work. Refrigeration at 2–8 °C is normal for stocks in active use. Freezing at −20 °C or below is used for longer holds, but it should be done in single-use aliquots: repeated freezing and thawing exposes the peptide to concentration and interfacial stresses at each transition and is a well-recognised cause of aggregation and loss.
Can I reconstitute a peptide with more diluent than the vial nominally holds?
Only up to the vial’s actual internal capacity, which is typically larger than the labelled fill volume — a 3 mL vial commonly accepts around 2–3 mL of liquid with headspace to spare. Adding more than the vial can hold risks pressurising the headspace and forcing solution back out around the needle. Check the physical vial size before planning a large dilution.
Does 99% purity on the COA mean 99% of the vial mass is peptide?
No. HPLC purity describes the proportion of peptide-related material that is the target sequence — it is a chromatographic area percentage. Net peptide content is a separate figure describing what fraction of the weighed mass is peptide rather than counter-ions, water and residual salts. Where molar accuracy matters, use net peptide content from the certificate of analysis.
References
- Wang W. Lyophilization and development of solid protein pharmaceuticals. International Journal of Pharmaceutics. 2000;203(1–2):1–60. PubMed
- Merck (Sigma-Aldrich). Synthetic peptide handling, solubility and storage protocol. Technical document. Protocol
- Roy S, Jung R, Kerwin BA, Randolph TW, Carpenter JF. Effects of benzyl alcohol on aggregation of recombinant human interleukin-1-receptor antagonist in reconstituted lyophilized formulations. Journal of Pharmaceutical Sciences. 2005. PubMed
- Hutchings RL, Singh SM, Cabello-Villegas J, Mallela KMG. Effect of antimicrobial preservatives on partial protein unfolding and aggregation. Journal of Pharmaceutical Sciences. 2013. Publisher
- United States Pharmacopeia. General Chapter <797> Pharmaceutical Compounding — Sterile Preparations. USP
- Chi EY, Krishnan S, Randolph TW, Carpenter JF. Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharmaceutical Research. 2003;20(9):1325–1336. PubMed
- Kristensen K, Henriksen JR, Andresen TL. Adsorption of cationic peptides to solid surfaces of glass and plastic. PLOS ONE. 2015;10(5):e0122419. PLOS ONE
- Manning MC, Chou DK, Murphy BM, Payne RW, Katayama DS. Stability of protein pharmaceuticals: an update. Pharmaceutical Research. 2010;27(4):544–575. PubMed
Research-grade peptides, batch-verified
GenoPept supplies lyophilised research peptides with a per-batch third-party certificate of analysis covering HPLC purity and mass spectrometry identity, dispatched from the UK, strictly for laboratory research.